UNIGE document Scientific Article
previous document  unige:32498  next document
add to browser collection
Title

Adalimumab in acute sciatica reduces the long-term need for surgery: a 3-year follow-up of a randomised double-blind placebo-controlled trial
Authors
Genevay, Stéphane
Finckh, Axel
Zufferey, P
Viatte, Sébastien
Balague, Federico
Gabay, Cem
Published in Annals of the rheumatic diseases. 2012, vol. 71, no. 4, p. 560-2
Abstract Two subcutaneous injections of adalimumab in severe acute sciatica significantly reduced the number of back operations in a short-term randomised controlled clinical trial.
Keywords Acute Disease — Adult — Anti-Inflammatory Agents/administration & dosage/therapeutic use — Antibodies, Monoclonal, Humanized/administration & dosage/therapeutic use — Back Pain/etiology — Diskectomy — Double-Blind Method — Female — Follow-Up Studies — Humans — Injections, Subcutaneous — Kaplan-Meier Estimate — Magnetic Resonance Imaging — Male — Middle Aged — Sciatica/complications/drug therapy/surgery — Treatment Outcome — Tumor Necrosis Factor-alpha/antagonists & inhibitors
Identifiers
PMID: 21998121
Full text
Article (Published version) (110 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Faculté de médecine / Section de médecine clinique / Département de médecine
Faculté de médecine / Section de médecine fondamentale / Département de pathologie et immunologie
Research group Mécanisme de l'inflammation articulaire (44)
Citation
(ISO format) 		GENEVAY, Stéphane et al. Adalimumab in acute sciatica reduces the long-term need for surgery: a 3-year follow-up of a randomised double-blind placebo-controlled trial. In: Annals of the rheumatic diseases, 2012, vol. 71, n° 4, p. 560-2. doi: 10.1136/annrheumdis-2011-200373 https://archive-ouverte.unige.ch/unige:32498

538 hits

0 download

Contact an author

Update request

Update

Deposited on : 2013-12-18

Export document
Format :
Citation style :